[Comparative study of the effect of different doses of human umbilical cord mesenchymal stem cells exosomes on intestinal barrier injury in severely burned rats]

Zhonghua Yi Xue Za Zhi. 2024 Dec 3;104(45):4153-4161. doi: 10.3760/cma.j.cn112137-20240715-01609.
[Article in Chinese]

Abstract

Objective: To explore the therapeutic efficacies of three different doses of human umbilical cord mesenchymal stem cell exosomes (hucMSC-EXO) on the injury of intestinal barrier structure and dysfunction in severely burned rats, and to identify the optimal dose of hucMSC-EXO for the repair of intestinal barrier injury. Methods: The hucMSC-EXO was isolated and identified by using an exosome extraction and purification kit. A total of 30 specific pathogen free (SPF) male Wistar rats (aged 6-8 weeks) were selected, and were randomly divided into five groups (n=6) using a random number table: sham group, burn group, burn+100 μg hucMSC-EXO group (Burn+EXO100), burn+200 μg hucMSC-EXO group (Burn+EXO200), and burn+400 μg hucMSC-EXO group (Burn+EXO400). The rats were immersed in 94 ℃ water, with the dorsal area exposed for 12 seconds and the ventral area for 6 seconds, to establish a 50% total body surface area (TBSA) third-degree burn model. The sham group rats were subjected under the same condition but with a 37 ℃ water bath. On day 1, 3, and 5 post-burn, the rats in sham group and burn group received an intraperitoneal injection of 0.5 ml phosphate buffered solution, and those in Burn+EXO100, Burn+EXO200, and Burn+EXO400 groups received intraperitoneal injections of 100, 200, and 400 μg/0.5 ml hucMSC-EXO, respectively. The activity of rats was observed and the weight was recorded daily. On day 7, the small intestine tissues and serum of the rats were collected. Hematoxylin-Eosin (HE) staining was used to observe the pathological changes of the small intestinal tissues, and the levels of inflammatory factors, such as tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6, IL-8, IL-10 and lipopolysaccharide (LPS) of small intestine tissues were detected by enzyme-linked immunosorbent assay (ELISA). The levels of diamine oxidase, D-lactic acid and bacterial endotoxin in serum were detected by intestinal barrier function biochemical analysis system. Results: The morphology of hucMSC-EXO was observed to be round or oval, with uniform size and a peak diameter of approximately 100 nm, expressing positive markers CD63 and TSG101. In the sham injury group, the rats' body weight increased by approximately (6.3±1.2) g/day, whereas in the burn group, the body weight significantly decreased on the first day post-injury and then gradually increased at a rate of (1.6±0.5) g daily. In contrast, the body weight of the Burn+EXO100, 200, and 400 groups increased at a rate of (2.9±1.1) g daily. By day 7 post-injury, the body weight in the Burn+EXO200 and Burn+EXO400 groups were significantly higher than those in the burn group and the Burn+EXO100 group (all P<0.05). HE staining showed that the villus height in the small intestine (duodenum, jejunum, ileum) of the burn group [(711±35), (526±25), (418±33) μm] was significantly reduced with severe structural damage, while the small intestine structure and villus height in the EXO-treated groups showed varying degrees of recovery. The villus height in the Burn+EXO200 group [(1 050±40), (798±30), (609±29)μm, respectively] and burn+EXO400 group [(1 102±46), (830±28), (625±33)μm, respectively] recovered significantly (all P<0.05). ELISA results indicated that the levels of pro-inflammatory cytokines TNF-α, IL-1β, IL-6, IL-8, and LPS in the burn group [(29.3±1.7), (81.2±2.5), (582.4±36.9), (22.1±0.6), (366.8±15.9)ng/L, respectively] were elevated, while those were significantly reduced in the EXO-treated groups, with Burn+EXO200 group [(17.9±1.0), (58.2±2.3), (206.6±38.7), (8.9±1.0), (94.9±7.3)ng/L, respectively] showing the most significant reduction (all P<0.05). The level of anti-inflammatory cytokine IL-10 was elevated in the burn group [(293.4±16.0) ng/L], and it was significantly increased in the burn+EXO100, 200, and 400 groups [(591.8±40.7), (672.5±53.7), (712.5±36.2)ng/L, respectively] (all P<0.05). Assessment of intestinal barrier function showed that serum diamine oxidase in the burn group decreased, while D-lactate and bacterial endotoxin increased. The EXO-treated groups demonstrated significant improvement in diamine oxidase, D-lactate, and bacterial endotoxin levels, with Burn+EXO200 group showing the most significant effect (all P<0.05). Conclusions: In this study, hucMSC-EXO was successfully isolated, extracted, and identified. An intraperitoneal injection of 200 μg of hucMSC-EXO demonstrates the most effective repair of intestinal structure and function in rats with severe burn injuries.

目的: 探讨3个不同剂量人脐带间充质干细胞外泌体(hucMSC-EXO)对严重烧伤大鼠肠屏障结构损伤和功能障碍的修复疗效,明确hucMSC-EXO修复治疗肠屏障损伤的最佳剂量。 方法: 使用外泌体提取纯化试剂盒分离提取hucMSC-EXO,并鉴定。选取30只无特定病原体级6~8周龄雄性Wistar大鼠,按照随机数字表法分为5组(n=6):假伤组、烧伤组、烧伤+100 μg hucMSC-EXO组(烧伤+EXO100)、烧伤+200 μg hucMSC-EXO组(烧伤+EXO200)、烧伤+400 μg hucMSC-EXO组(烧伤+EXO400)。大鼠经94 ℃水浴,背部12 s和腹部6 s致伤,建立总体表面积(TBSA)50%的Ⅲ度烧伤动物模型,假伤组大鼠相同条件下经37 ℃水浴。致伤后第1、3、5天,假伤组和烧伤组分别予以腹腔注射磷酸盐缓冲液0.5 ml,而烧伤+EXO100、烧伤+EXO200及烧伤+EXO400则分别予以腹腔注射100、200、400 μg/0.5 ml的hucMSC-EXO。每日观察大鼠活动状况并记录体重。致伤后第7天,采集各组大鼠小肠组织和血清,苏木精-伊红(HE)染色观察小肠组织的病理变化,酶联免疫吸附实验检测小肠组织中炎症因子肿瘤坏死因子-α(TNF-α)、白细胞介素-1β(IL-1β)、IL-6、IL-8、IL-10以及细菌脂多糖(LPS)的水平,肠道屏障功能生化指标分析系统检测血清中二胺氧化酶、D-乳酸和细菌内毒素的水平。 结果: hucMSC-EXO形态呈圆形或椭圆形,大小均匀,直径峰值约为100 nm,阳性表达CD63和肿瘤易感基因101(TSG101)。假伤组大鼠体重增长约(6.3±1.2)g/d,烧伤组体重在伤后第1天显著下降,随后以(1.6±0.5)g/d的速率缓慢增长;而烧伤+EXO100、200、400组大鼠体重增长速度为(2.9±1.1)g/d,其中伤后第7天烧伤+EXO200、400组体重高于烧伤组和烧伤+EXO100组(均P<0.05)。HE染色显示,烧伤组小肠组织(十二指肠、空肠、回肠)绒毛高度[(711±35)、(526±25)、(418±33)μm]明显缩短,结构损伤严重,而EXO处理组的小肠组织结构和绒毛高度均有所恢复,其中烧伤+EXO200组[(1 050±40)、(798±30)、(609±29)μm]及烧伤+EXO400组[(1 102±46)、(830±28)、(625±33)μm]绒毛高度显著恢复(均P<0.05)。烧伤组促炎因子TNF-α、IL-1β、IL-6、IL-8及LPS水平升高[(29.3±1.7)、(81.2±2.5)、(582.4±36.9)、(22.1±0.6)、(366.8±15.9)ng/L],而EXO各处理组较烧伤组显著降低,其中烧伤+EXO200组[(17.9±1.0)、(58.2±2.3)、(206.6±38.7)、(8.9±1.0)、(94.9±7.3)ng/L]效果最佳(P<0.05)。烧伤组抑炎因子IL-10水平[(293.4±16.0)ng/L]有所升高,烧伤+EXO100、200、400组[(591.8±40.7)、(672.5±53.7)、(712.5±36.2)ng/L]显著升高(均P<0.05)。肠道屏障功能检测结果显示,烧伤组血清二胺氧化酶水平下降,D-乳酸和细菌内毒素水平升高,EXO各处理组二胺氧化酶、D-乳酸及细菌内毒素水平显著改善,其中烧伤+EXO200组效果最佳(均P<0.05)。 结论: 成功分离、提取并鉴定了hucMSC-EXO,200 μg hucMSC-EXO腹腔注射剂量对严重烧伤大鼠肠道结构与功能修复效果最佳。.

Publication types

  • Comparative Study
  • English Abstract

MeSH terms

  • Animals
  • Burns*
  • Disease Models, Animal
  • Exosomes* / metabolism
  • Humans
  • Interleukin-6 / metabolism
  • Intestinal Mucosa / metabolism
  • Male
  • Mesenchymal Stem Cell Transplantation
  • Mesenchymal Stem Cells* / cytology
  • Rats
  • Rats, Wistar*
  • Tumor Necrosis Factor-alpha / metabolism
  • Umbilical Cord* / cytology

Substances

  • Tumor Necrosis Factor-alpha
  • Interleukin-6